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Abstract
When interest lies in assessing the effect of multiple treatments on
an outcome and an experiment is not feasible, a precise and rigorous
analysis of observational data can help address causal questions of in-
terest. This setting involves attempting to approximate an experiment
from observational data. With multiple treatments, this experiment
would be a factorial design. However, certain treatment combinations
may be so rare that, for some combinations, we have no measured out-
comes in the observed data. We propose to conceptualize a hypotheti-
cal fractional factorial experiment instead of a full factorial experiment
and layout a framework for analysis in this setting. We connect our
design-based methods to standard regression methods. We finish by
illustrating our approach using biomedical data from the 2003-2004
cycle of the National Health and Nutrition Examination Survey to
estimate the effects of four common pesticides on body mass index.
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1 Introduction
There has been a growth in the literature regarding the use of factorial de-
signs in causal inference, though primarily focusing on randomized experi-
ments (e.g. Branson et al., 2016; Dasgupta et al., 2015; Dong, 2015; Egami
and Imai, 2018; Espinosa et al., 2016; Lu, 2016a,b; Lu and Deng, 2017; Muk-
erjee et al., 2018; Zhao et al., 2018). These are settings in which we have
multiple treatments applied contemporaneously to subjects and interest is in
understanding not only the effect of a single treatment but also how treat-
ments may interact. A factorial experiment involves random assignment of
all possible treatment combinations to units and can be used to help un-
derstand these different effects. However, estimating the effect of multiple
treatments is not exclusively relevant for experiments, it is also of interest
when analyzing observational studies. In observational studies the mecha-
nism by which units receive different treatment combinations is unknown and
possibly related to unit-specific characteristics, which need to be accounted
for. Regression models with interaction terms are commonly used in obser-
vational studies to estimate the effects of multiple treatments (Bobb et al.,
2015; Oulhote et al., 2017; Patel et al., 2010; Valeri et al., 2017). For in-
stance, Bobb et al. (2015) considers a Bayesian kernel machine regression for
estimating the health effects of multi-pollutant mixtures. However, the use
of regression without a careful design phase, in which one tries to uncover or
approximate some underlying experiment, can lead to incorrect conclusions
(e.g., see Rubin, 2008).
We thus view the problem of estimating causal effects with multiple treat-
ments in an observational study through an experimental design perspective.
With a single binary treatment (or equivalently a single factor with two lev-
els), conceptualizing observational studies into plausible treatment-control
hypothetical randomized experiments has been a common strategy for es-
timating the causal effect of a treatment on an outcome (Bind and Rubin,
2017; Rosenbaum, 2002; Rubin, 2008; Stuart, 2010). This is achieved via
conceptual and design stages in which one attempts to approximate a ran-
domized experiment through methods that aim to balance treatment groups
with respect to covariates (Bind and Rubin, 2017; Imbens and Rubin, 2015;
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Rubin, 2008). Covariate balance is important not only to limit overt biases
(Rosenbaum, 2002, Chapter 3) but also to increase plausibility of assump-
tions that allow the analysis stage to be implemented with limited model
extrapolation (Imbens and Rubin, 2015, Chapter 12). For observational data
with multiple contemporaneously applied treatments, a factorial design is a
natural choice of experimental design. There have been some extensions of
matching techniques for a single binary treatment to multiple treatments.
For instance, Lopez and Gutman (2017) review and extend current methods
such as matching for obtaining causal estimates in observational studies with
multiple treatments, although they focus on multiple treatments meaning a
single factor with multiple levels, rather than multiple treatments that may
be applied contemporaneously. Nilsson (2013) considers matching using the
generalized propensity score (GPS) (Hirano and Imbens, 2004) in a 22 fac-
torial setting. However, further exploration of matching and other methods
that attempt to approximate an experiment in observational studies with
multiple treatments is still needed. We discuss obtaining covariate balance
further in Section 4.2.
An important issue with modeling multiple treatments in the observa-
tional setting, in addition to the usual concerns that we attempt to address
in the design phase, is that we may have limited data or no data available
for some treatment combinations. If a single treatment combination has no
measurements, then the recreation of a full factorial design is not possible.
Linear or additive regression models, often used in practice, will not be able
to recover a full factorial design and the implicit assumptions these regression
models are making about the missing treatment combinations in the analysis
are not transparent, especially with respect to the implicit imputation of the
missing potential outcomes. We further discuss regression estimates in such
setting in Section 4.4. When there are only one or two observations for a
certain treatment combination, utilizing a factorial design would rely heavily
on those few individuals being representative. We propose instead to embed
an observational study into a hypothetical fractional factorial experiment.
In this paper, we discuss the estimation of the causal effects of multiple
non-randomized treatments, in particular when we do not observe all treat-
ment combinations. First, Section 2 reviews full factorial designs within the
potential outcomes framework described in Dasgupta et al. (2015). Next,
Section 3 reviews extensions of this framework to fractional factorial designs
and expands upon current inference results. Then Section 4 examines how to
embed an observational study into a fractional factorial randomized exper-
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iment, and also discusses other methods in observational settings including
regression analyses and the use of incomplete factorial designs. Section 5
illustrates our method and challenges when working with observational data
with multiple treatments with an application examining the effects of four
pesticides on body mass index (BMI) using data from the National Health
and Nutrition Examination Survey (NHANES), which is conducted through
the Centers for Disease Control and Prevention (CDC). Finally, Section 6
concludes.
2 Full factorial designs
2.1 Set up
We work in the Rubin Causal Model (Holland, 1986), also known as potential
outcomes framework (Splawa-Neyman, 1990; Rubin, 1974). Additionally,
we assume the Stable Unit Treatment Value Assumption (SUTVA), that is,
there is no interference and no different forms of each treatment level (Rubin,
1980). Throughout this paper, we focus on two-level factorial and fractional
factorial designs. We closely follow the potential outcomes framework for 2K
factorial designs proposed by Dasgupta et al. (2015). We start by reviewing
the notation and basic setup.
Let there be K two-level factors; that is, there are K treatments (e.g.
medications), each having two levels (e.g. receiving a certain medication or
not receiving that medication) that are assigned in combination. This creates
2K = J total possible treatment combinations. Let zj denote the j
th treat-
ment combination. See Table 1 for an example where K = 3 which illustrates
the notation, with treatment combinations listed in lexicographic order (the
standard ordering, used here for consistency). Let zj,k ∈ {−1,+1} be the
level of the kth factor in the jth treatment combination, so zj = (zj,1, ..., zj,K).
The potential outcome for unit i under treatment combination zj is Yi(zj).
Let there be n units in the sample. The sample average potential outcome un-
der treatment zj is Y¯ (zj) =
∑n
i=1 Yi(zj)/n. Y¯ = (Y¯ (z1), Y¯ (z2), . . . , Y¯ (zJ))
is the vector of mean potential outcomes for all 2K treatment combinations.
Let Wi(zj) = 1 if unit i received treatment combination zj and Wi(zj) =
0 otherwise. As in Dasgupta et al. (2015),
∑J
j=1Wi(zj) = 1 and the observed
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potential outcome for unit i is
Y obsi =
J∑
j=1
Wi(zj)Yi(zj).
Let there be a fixed number, nj, of units randomly assigned to treatment
combination zj. That is, we are assuming a (possibly unbalanced) completely
randomized design. An estimator of the observed average potential outcome
for treatment zj is
Y¯ obs(zj) =
1
nj
n∑
i=1
Wi(zj)Yi(zj) =
1
nj
n∑
i:Wi(zj)=1
Y obsi .
Denote Y¯ obs = (Y¯ obs(z1), Y¯
obs(z2), . . . , Y¯
obs(zJ)) as the vector of observed
mean potential outcomes for all 2K treatment combinations.
Treatment 1 2 3 Outcomes
z1 -1 -1 -1 Y¯ (z1)
z2 -1 -1 +1 Y¯ (z2)
z3 -1 +1 -1 Y¯ (z3)
z4 -1 +1 +1 Y¯ (z4)
z5 +1 -1 -1 Y¯ (z5)
z6 +1 -1 +1 Y¯ (z6)
z7 +1 +1 -1 Y¯ (z7)
z8 +1 +1 +1 Y¯ (z8)
g1 g2 g3 Y¯
Table 1: Example of a 23 factorial design.
Using the framework from Dasgupta et al. (2015), denote the contrast
column j in the design matrix as gj, as illustrated in Table 1. Following that
paper, we can also define the contrast vector for the two-factor interaction
between factors k and k′ as
gk,k′ = gk ◦ gk′ ,
where ◦ indicates the Hadamard (element-wise) product. Similarly, the con-
trast vector for three-factor interactions is
gk,h,i = gk ◦ gh ◦ gi,
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and all higher order interaction contrast vectors can be calculated analo-
gously.
2.2 Estimands and estimators
Continuing to follow Dasgupta et al. (2015), define the finite population main
causal effect for factor k and the finite population interaction effect for factors
k and k′ as
τ(k) =
1
2K−1
gTk Y¯ and τ(k, k
′) =
1
2K−1
gTk,k′Y¯ ,
respectively, where by finite population we mean that we are only interested
in inference for the units we have in the experiment. Higher-level interaction
terms are defined analogously. We can similarly define the individual-level
effects as
τi(k) = g
T
k Yi and τi(k, k
′) =
1
2K−1
gTk,k′Yi,
where Yi = (Yi(z1), . . . , Yi(zJ))
T . We also define the average potential out-
come across treatments
τ(0) =
∑J
i=1 Y¯ (zk)
2K
=
1
2K
gT0 Y¯ ,
where g0 is a vector of length 2
K of all +1’s. The estimator for τ(k) and
τ(k, k′) are defined as
τ̂(k) =
1
2K−1
gTk Y¯
obs and τ̂(k, k′) =
1
2K−1
gTk,k′Y¯
obs,
respectively. Estimators for higher-level interaction terms and τ(0) are de-
fined analogously by replacing Y¯ by Y¯ obs.
In Dasgupta et al. (2015), the variance of the factorial effect estimators
was derived under a balanced design; however, the variance expression was
extended to unbalanced designs in Lu (2016b), as follows:
Var (τ̂(k)) =
1
22(K−1)
J∑
j=1
1
nj
S2(zj)− 1
n
S2k . (1)
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where
S2(zj) =
1
n− 1
n∑
i=1
(
Yi(zj)− Y¯ (zj)
)2
and S2k =
1
n− 1
n∑
i=1
(τi(k)− τ(k))2 .
An expression for the covariance between two factorial effect estimators was
provided by Dasgupta et al. (2015), which again can be extended to unbal-
anced factorial designs (Lu, 2016b):
Cov (τˆ(k), τˆ(k′)) =
1
22(K−p−1)
 ∑
j:gkj=gk′j
1
nj
S2(zj)−
∑
j:gkj 6=gk′j
1
nj
S2(zj)
− 1
n
S2k,k′ ,
(2)
where S2k,k′ =
∑n
i=1 (τi(k)− τ(k)) (τi(k′)− τ(k′)) /(n− 1).
2.3 Statistical inference
Among the various types of statistical analyses that could be performed for a
factorial design (e.g., Neymanian, frequentist linear regression, Fisherian, and
Bayesian), in this paper, we follow the Neymanian perspective. To do so, we
first need good estimators for the variances and covariances of the estimated
causal effects. A conservative Neyman-style estimator for the variance was
proposed by Dasgupta et al. (2015) and extended to the unbalanced case by
Lu (2016b):
V̂ar (τ̂(k)) =
1
22(K−1)
J∑
j=1
1
nj
s2(zj), (3)
where
s2(zj) =
1
nj − 1
∑
i:Wi(zj)=1
(
Yi(zj)− Y¯ obs(zj)
)2
is the estimated sampling variance of potential outcomes under treatment
combination zj. Dasgupta et al. (2015) discussed other variance estimators
and their performance under different assumptions (e.g. strict additivity,
compound symmetry). In that paper, the authors also provided a Neyman-
style estimator for the covariance by again substituting s2(zj) for S
2(zj).
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Unfortunately, this estimator is not guaranteed to be conservative because
S2k,k′ may be positive or negative. The same authors provided a Neyman
confidence region for τ , the vector of all J − 1 factorial effects. First, they
define, in Equation 26,
Tn = τˆ
T Σˆ−1τˆ τˆ ,
where τˆ is the vector of Neyman estimators of τ that we defined earlier and
Σˆτˆ is the estimator of the covariance matrix of τˆ , Στˆ . Then the 100(1−α)%
confidence region for τ (Equation 27 of Dasgupta et al. (2015)), is
{τˆ : pα/2 ≤ Tn ≤ p1−α/2},
where 0 < α < 1 and pα is the is the α quantile of the asymptotic distribution
of Tn. In that paper, a Neyman-style confidence interval for individual effects
was also provided:
τˆ(k)± zα/2
√
V̂ar (τ̂(k)),
where the authors rely on a normal approximation for the distribution of
τˆ(k), typically assumed to hold asymptotically.
Note that a model that linearly regresses an outcome against the factors
coded using contrast values −1 and +1 and all interactions between factors
(but no other covariates) will result in the same point estimates for the
factorial effects as presented here, divided by 2 (Dasgupta et al., 2015; Lu,
2016b). For a balanced design or when treatment effects are assumed to be
additive, so that the variances S2(zj) are all the same, the standard linear
regression variance estimator, relying on homoskedasticity, will be the same
as the Neymanian variance estimator (Dasgupta et al., 2015; Imbens and
Rubin, 2015). However, this is not true for an unbalanced design. Samii
and Aronow (2012) showed that the HC2 heteroskedasticity robust variance
estimator (see MacKinnon and White, 1985, for more details) is the same
as the Neymanian variance estimator presented here for a single treatment
experiment. Lu (2016b) extended this finding to factorial designs, showing
that this estimator is also the same as the Neymanian variance estimator in
that case. Note that because the regression estimator is different by a factor
of 2, this regression variance is different by a factor of 4.
Fisherian and Bayesian types of analyses are also possible. See Dasgupta
et al. (2015) for a discussion of creating “Fisherian Fiducial” intervals (Fisher,
1930; Wang, 2000) for factorial effects. The basic idea is to invert our esti-
mands so that we write our potential outcomes in terms of the estimands.
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Then, under a Fisher sharp null hypothesis, we can impute all missing poten-
tial outcomes and generate the randomization distribution. Dasgupta et al.
(2015) also provide an in-depth discussion of Bayesian analyses for factorial
designs.
3 Fractional factorial designs
3.1 Set up
There are situations in which a full 2K factorial design experiment cannot be
conducted or is not optimal. For instance, limited resources may mean there
are not enough units to randomly assign to each of the J (= 2K) treatment
combinations. Or the full factorial design might not be the most efficient
allocation of resources, for instance if the experimenter believes that higher
order interactions are not significant (Wu and Hamada, 2000). Instead, an
experimenter might implement a 2K−p = J ′ fractional factorial design in
which only J ′ of the total J treatment combinations are used (see, e.g., Wu
and Hamada, 2000). Here we will give a brief overview of this design, but we
recommend Wu and Hamada (2000) to obtain a much more detailed review.
We follow notation in Dasgupta et al. (2015) and Dasgupta and Rubin (2015).
To create a 2K−p design, we can write out a full factorial design for the
first K − p factors, and fill in the p columns for the remaining factors us-
ing multiplicative combinations of subsets of the previous contrast columns.
We use a generator to choose the factors whose treatment levels we multiply
together to get the treatment levels for the other factors (Wu and Hamada,
2000). For example, if we have want to create a 23−1 design using the gener-
ator 3 = 12, then we would start by writing out a 22 design for factors 1 and
2. Note that which two factors are used is irrelevant in this case because of
symmetry. However, with more complex aliasing structures this symmetry
may not hold and one should choose which factors to use based on the final
aliasing structure (discussed more below). Then we generate the third col-
umn, corresponding to treatment levels for factor 3, by multiplying together
the contrast vectors for factors 1 and 2. This design is shown in Table 2.
Under this design, the contrast columns are now different from the con-
trast columns of a full 23 factorial design. Again, note that, referring to
Table 2, g∗3 = g
∗
1 ◦ g∗2. The generator 3 = 12 means that the main effect
of factor 3 is aliased with the two-factor interaction 12. Two effects being
9
Treatment 1 2 3 Outcomes
z∗1 -1 -1 -1 Y¯ (z
∗
1)
z∗2 -1 +1 +1 Y¯ (z
∗
2)
z∗3 +1 -1 +1 Y¯ (z
∗
3)
z∗4 +1 +1 -1 Y¯ (z
∗
4)
g∗1 g
∗
2 g
∗
3 Y¯∗
Table 2: Example of a 23−1 factorial design.
aliased means that we cannot distinguish the effects – they are confounded
or combined in our estimators. The full aliasing in this design is as follows:
I = 123, 3 = 12, 2 = 13, 1 = 23. Note that I corresponds to a vector of
all +1’s (g0). The relation I = 123 is called the defining relation, which
characterizes the aliasing and how to generate the rest of the columns. We
see that the main effects are aliased with the two-factor interactions. If the
two-factor interactions are negligible, the 23−1 design is a parsimonious de-
sign to estimate the main effects. The resulting design is also orthogonal,
that is all of the pairs columns are orthogonal, and balanced, which means
that each g∗k has an equal number +1’s and -1’s (Wu and Hamada, 2000).
These properties give us nice simplifications of effects and aliasing structure.
We typically choose the generator or defining relation based on the max-
imum resolution criterion for the design. The resolution tells us about the
aliasing structure and indicates which levels of effects the main effects are
interacted with. Resolution is defined as the word length (i.e., the num-
ber of factors) in the shortest word of the defining relation (see Wu and
Hamada, 2000, for more details). In our example of a 23−1 design, we only
have one defining relation and the word is length 3. This means that the
main effects are aliased with two-factor interactions. We can imagine an al-
ternate aliasing structure in which some main effects are aliased with other
main effects. The effect hierarchy principle assumes that lower-order effects
are more significant than higher-order interaction effects (Wu and Hamada,
2000). Therefore, generally one chooses a fractional design where main ef-
fects, and some other lower-order interaction effects, are only aliased with
higher-order terms (Wu and Hamada, 2000). In particular, we may want our
main effects and two-factor interactions to be clear or strongly clear. This
assumption goes along with the assumption of effect sparsity, that the num-
ber of significant or important effects is small, as a justification of the use of
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fractional designs over the full factorial (Wu and Hamada, 2000).
3.2 Estimators
We now review estimators for the fractional design, which are similar to the
full factorial case. We follow the framework laid out in Dasgupta et al. (2015)
and Dasgupta and Rubin (2015). The estimator for τ(k) is defined as
τ̂ ∗(k) =
1
2K−p−1
g∗Tk Y¯
obs
∗ .
The estimator for τ(k, k′) is defined as
τ̂ ∗(k, k′) =
1
2K−p−1
g∗Tk,k′Y¯
obs
∗ .
Note that these estimators are no longer unbiased. Let S be the set of all
effects aliased with factorial effect k, including k. The number of factors
aliased with factor k is 2p − 1 (Montgomery, 2017, Chapter 8). So, S has
2p elements. Factor k may be aliased with the negative of a main effect or
interaction. Let Sk,j be the indicator for whether factor j is negatively aliased
with factor k (Sk,j = 1) or positively aliased (Sk,j = 0). Then we find, using
the orthogonality of the gk vectors, that
E [τ̂ ∗(k)] =
1
2K−p−1
g∗Tk Y¯∗
=
∑
j∈S
(−1)Sk,jτ(j)
= τ(k) +
∑
j∈S\{k}
(−1)Sk,jτ(j).
Hence by aliasing these effects, we are grouping them all together.
We see that the estimator for τ(k) is unbiased if the effects aliased with
factorial effect k are zero, and will be close to unbiased as long as the aliased
effects are negligible, which may be justified by the effect hierarchy princi-
ple. When aliasing occurs such that main effects are aliased with low-order
interaction terms, such as two-factor interactions, this assumption may be
unrealistic. However, if we have a large number of factors and are only
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aliasing main effects with higher-order effects, this may be reasonable. For
instance, in a 26−1 fractional design, main effects are aliased with five-factor
interactions and two-factor interactions are aliased with four-factor interac-
tions, where both higher-order interactions may be assumed to be small.
Now we extend the variance and variance estimator expressions from
Dasgupta et al. (2015) (see Section 2) to this setting. Recall J ′ = 2K−p
and define τ˜(k) = E[τ̂ ∗(k)]. Further define the analog of S2k ,
S˜2k =
1
n− 1
n∑
i=1
(τ˜i(k)− τ˜(k))2 ,
which is the variation in our newly defined aliased main effects, τ˜i(k). Let
n∗j be the number of units assigned to treatment combination z
∗
j . Then the
variance of the estimator τˆ ∗(k) is
Var (τˆ ∗(k)) =
1
22(K−p−1)
1
n∗j
J ′∑
j=1
S2(z∗j )−
1
n
S˜2k . (4)
See Appendix A.2 for more details on this derivation. Similarly, we can
obtain the covariance between two fractional factorial effect estimators. Here
we define an altered version of S2k,k′ :
S˜2k,k′ =
1
n− 1
n∑
i=1
(τ˜i(k)− τ˜(k)) (τ˜i(k′)− τ˜(k′)) . (5)
Then, the covariance of τˆ ∗(k) and τˆ ∗(k′) is
Cov (τˆ ∗(k), τˆ ∗(k′)) =
1
22(K−p−1)
 ∑
j:g∗kj=g
∗
k′j
1
n∗j
S2(z∗j )−
∑
j:g∗kj 6=g∗k′j
1
n∗j
S2(z∗j )
− 1
n
S˜2k,k′ .
(6)
See Appendix A.3 for more details on this derivation.
The variance expressions for fractional factorial designs are similar to the
full factorial case, but are now defined over aliased or grouped effects.
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3.3 Statistical inference
It is straightforward to extend the analysis for factorial designs in Dasgupta
et al. (2015) and reviewed in Section 2 to fractional factorial designs. We
can again use a conservative Neyman-style variance estimator:
V̂ar (τˆ ∗(k)) =
1
22(K−p−1)
1
n∗j
J ′∑
j=1
s2(z∗j ). (7)
This leads to
E
[
V̂ar (τˆ ∗(k))
]
=
1
22(K−p−1)
1
n∗j
J ′∑
j=1
S2(z∗j )
and thus V̂ar (τˆ ∗(k)) is a conservative estimator and unbiased if and only if
S˜2k = 0, which would occur if the aliased effects τ˜i(k) are constant. Note
that this situation occurs when all effects aliased with factor k are constant
additive effects.
We can build confidence regions and confidence intervals analogously to
what was reviewed in Section 2.3.
As in the full factorial setting, linear regression yields the same point
estimates (divided by 2) and the HC2 variance estimator yields the same
variance estimate (divided by 4) as the Neymanian estimates. For proof, see
Appendix B.
4 Embedding observational studies in frac-
tional factorial designs
4.1 General issues
To address causality in a non-randomized study, it has been argued that the
dataset should be first described as a hypothetical randomized experiment
(Bind and Rubin, 2017; Rosenbaum, 2002; Rubin, 2008; Stuart, 2010). The
hypothetical randomization is plausible if the treatment groups are “similar”
with respect to confounding variables (Rubin, 2007, 2008). In a setting with
multiple treatments of interest, we recreate a hypothetical factorial random-
ized experiment. However, in observational studies, there may be no units
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that received certain treatment combinations. Therefore, our strategy is to
recreate a hypothetical fractional factorial experiment instead of a full fac-
torial experiment.
The choice of fractional factorial design to recreate should be based on
some criteria such as the maximum resolution criteria and typically aliasing
main effects with the highest order interactions, which usually means a small
p, i.e. small fraction of total design removed, is preferred. In practice, we
may not be able to control the aliasing structure. We must choose an aliasing
structure for the 2K−p fractional design such that the treatment combination
with no observations is not used. However, this strategy usually results in
the removal of units assigned to treatment combinations that were present
in the observational data set but not used in the design. That is, if only one
treatment combination is not present in the data set, we could use a 2K−1
design, but then we are not using 2K−1−1 treatment combinations for which
we have data.
After a design is chosen, a strategy to balance covariates should be used
to ensure that the units across treatment combinations are similar with re-
spect to background covariates. We assume strong ignorability, that is, that
conditional on measured covariates, the assignment mechanism is individual-
istic, probabilistic, and unconfounded (Rosenbaum and Rubin, 1983). Then
we can obtain unbiased causal estimates by analyzing the data as if it arose
from a hypothetical randomized experiment. Note that these assumptions
must also apply to treatment combinations that were not observed in the data
set. For the probabilistic assignment we must assume that each individual
in our final data set (after matching or trimming) has a positive, although
possibly very small, probability of having been assigned to any treatment
combination, even those that no one received. If a single unit has zero prob-
ability of receiving a certain treatment combination, they should not be in
our hypothetical experiment. If all units have zero probability of receiving a
certain treatment combination, then then the average potential outcome un-
der that treatment combination is likely not of scientific interest. In that case,
we would need to consider a causal estimand that does not depend on this
unmeasurable potential outcome. Hence, it is important that subject mat-
ter knowledge guides us in deciding which covariates are informative about
which units have positive probability of receiving all treatment combinations.
A similar argument must hold for the unconfoundedness assumption. The
unconfoundedness assumption is often assumed when reasonable covariate
balance is achieved (Imbens and Rubin, 2015).
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Achieving covariate balance in multiple treatment groups in non-randomized
studies can be non-trivial. We discuss this issue further in the context of hy-
pothetical fractional factorial designs in Section 4.2. Therefore, a first step
might be to only obtain covariate balance between two treatment groups, a
task commonly done in the causal inference literature, and compare outcomes
for these groups. For instance, we could estimate the difference in outcomes
between the units that were assigned level +1 for all factors and the units
that were assigned −1 for all factors. Under certain assumptions, testing the
difference in these groups can act as a global test for whether any effects of
interest are significant. We discuss the test and assumptions that are needed
for this simple comparison to be meaningful in Section 4.3.
Once we have decided to recreate a particular fractional factorial design
and have obtained a data set with covariate balance, estimation and infer-
ence can follow in a similar way to Section 3. However, as mentioned earlier,
fractional factorial designs may discard units. Therefore we explore alter-
native incomplete factorial designs in Section 4.4. These designs use some
portion of the data, but not necessarily the portion that would have been
chosen when recreating a fractional factorial design. Additionally, these de-
signs may be estimand-specific such that multiple different designs may be
used with different estimands.
4.2 Covariate balance
An important stage when estimating the causal effect of non-randomized
treatments is the design phase (Rubin, 2007, 2008). At this stage, we attempt
to obtain a subset of units for which we can assume unconfoundedness. That
is, units for which P (Wi|Yi(z),Xi) = P (Wi|Xi) whereXi is a m-dimensional
vector of covariates (Imbens and Rubin, 2015). Matching strategies are often
used to ensure no evidence of covariate imbalance between treatment groups,
as reviewed by Stuart (2010). Note that matching often involves removing
units, which means that the statistical analysis is generally performed on a
subset of the original study population. This implies that the population
of units we are doing inference with respect to may change after trimming
units. In settings with multiple treatments, matching can be difficult. There
have been extensions of propensity score balancing to multiple treatments,
most notably the generalized propensity score (GPS) (Hirano and Imbens,
2004) and more recently the covariate balancing propensity score (CBPS)
(Imai and Ratkovic, 2014) was introduced and shown to extend to multiple
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treatments. Lopez and Gutman (2017) review techniques, including match-
ing, for observational studies with multiple treatments and although they do
not explore factorial (full or fractional) designs, it may be straightforward to
extend their methods to this design. Nilsson (2013) discusses matching in
the 22 design. Recent work by Bennett et al. (2018) uses template match-
ing, which matches units to a “template” population of units, for multiple
treatments, though again not with factorial designs. Therefore, methods for
creating covariate balance specifically for factorial type designs require fur-
ther exploration. In our data illustration in Section 5, we employ sequential
trimming and checks on covariate balance, as discussed below.
Testing for covariate imbalance across multiple treatment groups can be
done using multivariate analyses of variance (MANOVA), which uses the
covariance between variables to test for mean differences across treatment
groups, as used in Branson et al. (2016). Recall that the factorial design has
J treatment combinations. Define the following H and E matrices (Coombs
and Algina, 1996):
H =
J∑
k=1
nk(Xk −X)(Xk −X)T
E =
J∑
k=1
(nk − 1)Sk, where Sk = 1
nk − 1
nk∑
j=1
(Xkj −Xk)(Xkj −Xk)T ,
whereXk is the m-dimensional vector of mean covariate values for treatment
group k, X is the average m-dimensional vector of mean covariate values for
all units, that is X =
∑J
k=1
nk
n
Xk, and Xkj is the m-dimensional vector of
covariates for the jth unit in treatment group k. Denote by θk the ordered
eigenvalues of HE−1, where k ∈ {1, ..., s} and s = min(m,K− 1). Standard
MANOVA statistics which can be used to test covariate balance are typically
functions of the eigenvalues ofHE−1 (Coombs and Algina, 1996). We choose
the Wilks’ statistic (Wilks, 1932):
Wilks =
|E|
|H|+ |E| =
K∏
k=1
1
1 + θk
,
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where θk corresponds to the k
th eigenvalue of HE−1.
As discussed in Imai et al. (2008), a potential drawback of testing for
evidence against covariates imbalance is that as we drop units we lose power
to detect deviations from the null hypothesis of no difference in covariates
between the treatment groups. Another diagnostic for covariate balance
is checking covariate overlap via plots and other visual summaries of the
data. So called “Love plots”, which show standardized differences in co-
variate means between two treatment groups before and after adjustment
(Ahmed et al., 2006), are difficult to generalize directly because of the mul-
titude of treatment groups and comparisons. However, plots of standardized
means or of distributions may be helpful to detect imbalance.
4.3 Initial test for significance of effects
As discussed in the previous section, achieving covariate balance for more
than two treatment groups can be a challenge. Therefore instead of attempt-
ing to achieve balance among all treatment groups, a simple first step might
be to examine two carefully chosen treatment groups and attempt to balance
these two groups only. Obtaining balance between two treatment groups
has been well-studied in causal inference, see Stuart (2010) for a review of
common matching methods for such settings. Once significant covariate im-
balance can be ruled out, we can test whether the mean difference between
these two groups is significantly different. But what can we learn from this
comparison about our factorial effects?
First consider a full factorial model matrix, including interactions and the
mean, which we denote by G and whose rows are comprised of gTk , where k
∈ {1; ...;K; 1, 2; ..., K− 1, K; ...; 0}. Based on the definition of our estimands
in Section 2.2, the matrix G relates the mean potential outcomes and the
factorial effects as follows:
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2−(K−1)

gT0
gT1
...
gTK
gT1,2
...
gTK−1,K
...
gT1,2,...,K−1,K

︸ ︷︷ ︸
G

Y¯ (z1)
Y¯ (z2)
...
Y¯ (zJ)

︸ ︷︷ ︸
Y¯
=

2τ(0)
τ(1)
...
τ(K)
τ(1, 2)
...
τ(K − 1, K)
...
τ(1, 2, ..., K − 1, K)

︸ ︷︷ ︸
τ
.
Note that the inverse of G is simply GT rescaled (i.e., G−1 = 1
2k
GT ) because
of orthogonality, as argued by Dasgupta et al. (2015) in the context of im-
puting potential outcomes under Fisher’s sharp null hypothesis. The mean
potential outcomes can be rewritten in terms of the factorial effects as
Y¯ =
1
2
GTτ .
Let the jth row of GT be denoted by hj, which is the sign of each of the
average causal effects that aggregate to create the potential outcome Y¯ (zj).
The first entry of hj is +1, corresponding to the mean, the next K entries
are equal to the entries of zj, and the remaining entries correspond to inter-
actions, with the order given by the order of the rows of G. We have
Y¯ (zj) =
1
2
hjτ .
So when we subtract two observed means, assuming that the observed means
are unbiased estimates of the true means (i.e. we have randomization or
strong ignorability), we are estimating
Y¯ (zj)− Y¯ (zj′) = 1
2
(hj − hj′)τ ,
which is the sum of terms that are signed differently in hj and hj′ .
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As an example for a 23 design, we have the following matrix for GT :
GT =

h1
h2
h3
h4
h5
h6
h7
h8

=

+1 −1 −1 −1 +1 +1 +1 −1
+1 −1 −1 +1 +1 −1 −1 +1
+1 −1 +1 −1 −1 +1 −1 +1
+1 −1 +1 +1 −1 −1 +1 −1
+1 +1 −1 −1 −1 −1 +1 +1
+1 +1 −1 +1 −1 +1 −1 −1
+1 +1 +1 −1 +1 −1 −1 −1
+1 +1 +1 +1 +1 +1 +1 +1

.
Now consider taking the difference between Y¯ (z8)−Y¯ (z1) = Y¯ (+1,+1,+1)−
Y¯ (−1,−1,−1), which yields
Y¯ (z8)− Y¯ (z1) = 1
2
(h8 − h1)τ
= τ(1) + τ(2) + τ(3) + τ(123).
Note that testing whether the difference between Y¯ (z8) and Y¯ (z1) is zero
is the same as testing whether τ(1) + τ(2) + τ(3) + τ(123) is zero. If it is
reasonable to assume that all main effects are of the same sign based on
subject matter knowledge and that the three-factor interaction is also of
the same sign or negligible, then this global test of whether there are any
treatment effects is relevant to the estimand of interest. According to the
effect hierarchy principle (Wu and Hamada, 2000), the main effects should
dominate the three-factors interaction. Hence, even if the interaction differs
in sign, we would expect to see an effect under this assumption if there is
one. If the global test is not rejected, then we would move on to recreating
the entire factorial design. If it is unclear whether the signs of the effects are
the same (also referred as antagonistic effects), then this global test would
be inappropriate because effects could still be different from zero but their
sum could be (close to) zero.
If we are particularly interested in the causal effects involving the first
factor, we can create a test specifically for those effects. For instance in the
the 23 setting, we might use the estimand Y¯ (z8)− Y¯ (z4) as a proxy for the
effect of the first factor, as follows:
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Y¯ (z8)− Y¯ (z4) = Y¯ (+1,+1,+1)− Y¯ (−1,+1,+1)
=
1
2
(h8 − h4)τ
= τ(1) + τ(12) + τ(13) + τ(123). (8)
In Equation 8, if all terms have the same sign and we find that the
difference is significantly different than zero, then we would conclude that
factor 1 has an effect, either on its own or through interactions with the
other factors. Alternatively, we may be interested in comparing the mean
potential outcome when a particular factor is high and all of the other factors
are low versus the mean potential outcome when all factors are low. This
comparison yields different signs for some terms, compared to Equation 8:
Y¯ (z5)− Y¯ (z1) = Y¯ (+1,−1,−1)− Y¯ (−1,−1,−1)
=
1
2
(h5 − h1)τ
= τ(1)− τ(12)− τ(13) + τ(123).
The choice of which levels to compare should be based on subject matter
knowledge and reasonable assumptions.
To reiterate, throughout this section we focused on the meaning of several
estimands, which are easily estimated under a randomized experiment. In an
observational study, we would first need to obtain balance for any treatment
groups we would be using in our estimator.
4.4 Incomplete factorial designs
In this section, we discuss alternative experimental designs to the fractional
factorial design, in particular the incomplete factorial design which uses a
subset of data from a full factorial design but differently from a fractional
design (Byar et al., 1993). We discuss aspects of incomplete factorial designs,
which were originally discussed in Byar et al. (1993), but with a design-
based and potential outcome perspective. Throughout this section we assume
that we have obtained covariate balance, as discussed in Section 4.2, thereby
proceeding as if the observational data arose from a hypothetical randomized
experiment.
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If an observational study is missing outcome measurement for one treat-
ment combination only, a natural question is whether the fractional factorial
design, which requires removing multiple treatment groups, is the best choice.
For instance, we may have a factorial design as in Table 3 that is missing
outcome measurements for treatment combination z7.
Treatment 1 2 3 Observed Outcomes
z1 -1 -1 -1 Y¯
obs(z1)
z2 -1 -1 +1 Y¯
obs(z2)
z3 -1 +1 -1 Y¯
obs(z3)
z4 -1 +1 +1 Y¯
obs(z4)
z5 +1 -1 -1 Y¯
obs(z5)
z6 +1 -1 +1 Y¯
obs(z6)
z7 +1 +1 -1 ?
z8 +1 +1 +1 Y¯
obs(z8)
g1 g2 g3 Y¯
obs
Table 3: Example of a 23 factorial design with no observations for some
treatment combinations.
Let us focus on estimation of τ(1) first. If we recreate a fractional facto-
rial design that aliases the main effects with the two-way interaction, then
we estimate τ(1)+τ(23), which would involve using outcome data from units
assigned to treatment combinations z2, z3, z5, and z8, but not from units as-
signed to treatment combinations z1, z4, and z6. Instead, we might consider
not including treatment combination z3 in our estimator, which has the same
levels for factors 2 and 3 but the opposite level for factor 1 as combination z8.
Thus, in some sense, removing z3 “balances out” the remaining treatment
combinations and is essentially the “na¨ıve estimator” discussed in Byar et al.
(1993). This strategy creates a different hypothetical experimental design
with a different aliasing structure. In this case, we would be estimating
τ˙(1) =
Y¯ (z5) + Y¯ (z6) + Y¯ (z8)
3
− Y¯ (z1) + Y¯ (z2) + Y¯ (z4)
3
=
τ(1|F2 = −1, F3 = −1) + τ(1|F2 = −1, F3 = +1) + τ(1|F2 = +1, F3 = +1)
3
,
where we let Fk denote the factor level of the k
th factor so that
τ(k|Fj = x, Fi = y) is the main effect of factor k conditional on level x of
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factor j and level y of factor i, as in Dasgupta et al. (2015). That is, we esti-
mate the average of the conditional effects of factor 1 given the combinations
(-1,-1), (-1,+1), and (+1,+1) for factors 2 and 3, respectively.
To find the aliasing structure, we can consider the perspective of Sec-
tion 4.3. Referring to the matrix GT in that section, we can rewrite the
estimand above as
τ˙(1) =
1
3
1
2
(h8 + h6 + h5 − h4 − h2 − h1) τ
= τ(1) +
−τ(13) + τ(23) + τ(123)
3
.
Now we have aliased the main effect for factor 1 with the two-factor
interactions for factors 1 and 3 and factors 2 and 3, as well as the three-factor
interaction, all divided by three. This is partial aliasing because the factors
are not fully aliased or completely clear of each other (Wu and Hamada,
2000, Chapter 7). Whether this is preferable to aliasing the main effect with
just the two-factor interaction between factors 2 and 3 depends entirely on
subject-matter knowledge. For instance, if we know that the three-factor
interaction is negligible, then we might expect this design to have lower bias,
as we are dividing both two-factor interactions by 3. However, even if we had
knowledge that the two-factor interactions were of the same sign, we would
not know the direction of the bias in this case without knowing the relative
magnitudes of the two-factor interactions. When estimating the main effect
for factor 2, we would naturally approximate a different design. In that case,
using the same logic as before, we would remove the treatment combination
z5.
As an alternative design, we may alias our main effects with the highest-
order interaction possible, allowing for a different design for each main effect
estimator. So when estimating the main effect of factor 1, we would use a
design that aliases factor 1 with the three-factor interaction. This leads to
a design using treatment combinations z1, z4, z5, and z8 for which we can
build the following estimand:
τ˙(1) =
Y¯ (z5) + Y¯ (z8)
2
− Y¯ (z1) + Y¯ (z4)
2
=
1
2
1
2
(h8 + h5 − h4 − h1) τ
= τ(1) + τ(123).
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Based on the hierarchy principle, an estimator with this aliasing structure
should be a superior estimator to the original fractional factorial estimator
mentioned because the three-factor interaction is more likely to be negligible
than the two-factor interactions.
Denote by g˜k the analog of gk with zeros where outcome data are missing
or excluded in a given design. If there is a single treatment combination with
no outcome measured, we can choose the aliasing such that factor k is aliased
with the K-factor interaction. When more rows are missing, the pattern of
missingness will dictate what aliasing structure is possible. For example, if
we are missing two rows but they are missing from the same design that
aliases factor k with the negative of the K-factor interaction, then we can
still recreate the design that aliases factor k with the positive of the K-factor
interaction. But if we are missing a row from each of these designs, neither
option is possible and we must choose a different aliasing structure. If this
method is continued for each factor, one ends up with a set of g˜k, each with
zeros for different treatment combinations.
Section 4.5 of Wu and Hamada (2000) gives a general strategy to design
experiments while trying to reduce aliasing for certain main effects. There
are also other designs we can construct, such as nonregular designs that have
partial aliasing (see Wu and Hamada, 2000, Chapter 7 for more details on
nonregular designs).
More generally, denote our estimator for kth factor under one of these
alternative incomplete factorial designs as ˆ˙τ(k) = g˜Tk Y¯
obs. It is straightfor-
ward to extend the variance expression Var
(
ˆ˙τ(k)
)
and variance estimator
V̂ar
(
ˆ˙τ(k)
)
from Section 3.3 to these alternative designs by following a sim-
ilar proof as in Appendix A.2. Calculating the covariance of ˆ˙τ(k) and ˆ˙τ(k′)
will be similar to Section 3.3 and Appendix A.3. However, terms for some
treatment combinations will be set to zero because they are present in one
estimator but not the other.
If we run a regression with all interactions on a design with missing treat-
ment combinations, it is ambiguous what design the resulting estimators
correspond to and, as discussed above, multiple designs may be plausible to
approximate the observational study. Although the estimators provided may
be sensible, the practitioner should be careful to assess what aliasing struc-
ture the regression implies, as this is not obvious from the computer output
alone. Byar et al. (1993) and Byar et al. (1995) give more discussion of these
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types of estimators. Also see further discussion in Appendix C.3.
So far this discussion has focused on randomized treatments, or hypothet-
ical ones from an observational study. However, in an observational study,
if we attempt to use a different design for each estimator there may be com-
plications. If no outcome is measured for one treatment combination, we
would use all 2K − 1 treatment combinations if we did an analysis for all
effects and used a different design for each. This approach would require
us to either first obtain balance among all 2K − 1 treatment groups or to
obtain balance among the treatment groups within each design separately.
The former option may be difficult; as the number of treatment combina-
tions grows, obtaining covariate balance across all treatment groups becomes
increasingly difficult and may result in smaller and smaller sample sizes, es-
pecially if trimming is used. The latter option will make joint inferences,
which is challenging because different units would be used in each analysis.
Therefore, although these incomplete factorial designs may improve the
bias of our estimators, the fractional factorial design in which we are using
the same 2K−p rows may be more attractive from a practical standpoint, in
terms of obtaining covariate balance. The fractional factorial design is also a
classical experimental design and the aliasing structure is easy to understand.
5 Data illustration
5.1 Data description
Here we give an illustration of the implementation of our methods using data
on pesticide exposure and body mass index (BMI). We use the 2003-2004 cy-
cle of the National Health and Nutrition Examination Survey (NHANES)
collected by the Centers for Disease Control and Prevention (CDC). We ac-
cess the data via the R (R Core Team, 2017) package RHANES (Susmann,
2016). We focus on four organochlorine pesticides, measured via a blood
serum test and then dichotomized based on whether they were above (+1)
or below (-1) the detection limit, as given in the NHANES dataset, as fac-
tors. Organochlorine pesticides are persistent in the environment and adverse
health effects have been reported by the CDC (2009), making them an inter-
esting group of pesticides to study. To keep this illustration simple, we chose
to use only four pesticides and those were chosen primarily based on data
availability and exposure rates. That is, some pesticides were so common
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(or rare) that virtually everyone (or no one) in the data set was above the
detection limit (or below the detection limit). The following are the the four
pesticides that were chosen: beta-Hexachlorocyclohexane (beta-Hex), hep-
tachlor epoxide (Hept Epox), mirex, and p.p’-DDT. Previous findings of an
association between pesticide exposures and body mass index (BMI) (Buser
et al., 2014; Ranjbar et al., 2015) led us to choose BMI as the outcome of
interest. BMI is the ratio between weight and height-squared.
We removed 271 units with missing values of pesticide and BMI obser-
vations, noting that because this is an illustration and not intended to draw
causal conclusions we drop those units for simplicity. Farmers are more likely
to be exposed to pesticides than the general population, here we decided to
study a non-farmer population, our first step to achieving covariate balance,
leaving a dataset with 1,259 observations (see Figure 5 in the Appendix for
more).
5.2 Design stage
To show the process of how estimands change as we adjust our design stage,
we consider different “designs.” First we consider analyzing the data as if
it came from a 24 factorial hypothetical experiment, without adjusting the
sample to balance for covariates. Second, we instead analyze the data as if it
came from a fractional factorial 24−1 hypothetical experiment to assess how
estimates change when going from a factorial design to a fractional factorial
design. Finally, we trim units to obtain a fractional factorial 24−1 hypo-
thetical experiment with covariate overlap and with no evidence of covariate
imbalance with respect to gender, age, and smoking status, to see how esti-
mates change when a true design phase with the aim of obtaining covariate
balance is implemented.
Note that we trim units to obtain better balance on gender, age, and
smoking status as these are our first tier of most important covariates. Then
additional adjustment for our second tier of covariates, race and ethnicity and
income, are done via linear regression, as described in the following section.
We also found that even with trimming, gender and smoking status were
imbalanced across the treatment groups so these were also adjusted for in
the linear regression.
There are a few notes on the definitions of these covariates. From now
on we will refer to the “race and ethnicity” covariate as simply ethnicity,
as a short hand and to make clear that this is one categorical variable in
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the NHANES dataset. The income variable is defined as annual household
income. For categorizing individuals as smokers vs non-smokers, we use the
question “Have you smoked at least 100 cigarettes in your life time?” and
we categorized “Yes” and “Don’t know” as smokers. Note that only one
observation with value “Don’t know” was recorded.
5.3 Statistical analysis
We analyzed the three datasets described in the design stage using:
• a multiple linear regression that regresses BMI on treatment factors;
• a multiple linear regression that regresses BMI on treatment factors, as
well as the following covariates, as factors: ethnicity, income, gender,
and smoking status;
• Fisher-randomization tests of the sharp null hypothesis of no treatment
effects.
Recall from Sections 3.3 and 2.3 that regression estimates when including
all factors and interactions, but not covariates, are our standard Neymanian
estimates divided by two. Figures 19 and 20 in Appendix D.3.2 show that
further adjustment for ethnicity and income are needed, even after balancing
gender, age, and smoking status. Additional data descriptions and the full
statistical analyses are available in Appendix D. Note that due to the right-
skewed nature of the weight variable, BMI exhibits some degree of right-
skewness. Therefore we use log-transformed BMI as the outcome in these
analyses.
5.3.1 Full factorial design
Table 4 provides the counts of observations for each treatment combination
(zj). We had 1,259 units in this dataset, although when adjusting for co-
variates in the regression, units with missing covariate values were removed
resulting in 1,183 units. We see that factor combination 10 (z10) has only
one observation. Relying on only one observation for a treatment combina-
tion will lead to unstable estimates. Hence, Section 5.3.2 aims to avoid this
issue by embedding the observational study in a fractional factorial hypo-
thetical experiment. Nonetheless, we perform the analysis of the 24 factorial
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hypothetical experiment in this section and will compare the results to the
analysis of the fractional factorial hypothetical experiment. Because there
is only one unit assigned to z10, it is not possible to estimate Neymanian
variances here. See Appendix D.1 for full analysis results.
Factor Levels Number of Obs.
beta-Hex Hept Epox Mirex p,p’-DDT
z1 -+1 -+1 -+1 -+1 426
z2 +-1 -+1 -+1 -+1 12
z3 -+1 +-1 -+1 -+1 70
z4 +-1 +-1 -+1 -+1 51
z5 -+1 -+1 +-1 -+1 291
z6 +-1 -+1 +-1 -+1 25
z7 -+1 +-1 +-1 -+1 94
z8 +-1 +-1 +-1 -+1 54
z9 -+1 -+1 -+1 +-1 21
z10 +-1 -+1 -+1 +-1 1
z11 -+1 +-1 -+1 +-1 19
z12 +-1 +-1 -+1 +-1 19
z13 -+1 -+1 +-1 +-1 42
z14 +-1 -+1 +-1 +-1 19
z15 -+1 +-1 +-1 +-1 37
z16 +-1 +-1 +-1 +-1 78
g1 g2 g3 g4 1259
Table 4: Counts of observations for each treatment combination of the pes-
ticides with farmers removed for the factorial design. Red rows treatment
combinations that we will use when recreating a fractional factorial design.
5.3.2 Fractional (24−1) factorial design
In the 24−1 fractional factorial design, instead of using I = 1234, we chose
I = −1234 to exclude row 10 in Table 4 that has only a single observation.
The dataset in this hypothetical experiment consists of 523 observations.
However, when adjusting for covariates in the regression, units with missing
covariate values were removed resulting in 488 units. In this design, aliasing
is as follows: I = −1234, 4 = −123, 3 = −124, 2 = −134, 1 = −234,
12 = −34, 13 = −24, 14 = −23. The main effects are aliased with the
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negative of the three-factor interactions and the two-factor interactions are
aliased with each other with reversed signs. In order to identify main effects,
we will assume that the three-factor interaction is negligible. In practice,
researchers should assess whether this aliasing assumption is realistic. See
Appendix D.2 for full analysis results.
5.3.3 Fractional factorial design with no evidence of covariate im-
balance
We examined the distributions across treatments of the following covariates:
gender (recorded as male vs. female), smoking status (smoker vs. non-
smoker, as defined earlier), and age at the time of survey (in years). Figure 1
shows covariate imbalance with respect to gender, smoking, and age in the
fractional factorial design.
We used a rejection approach that sequentially pruned the observations of
the fractional factorial dataset until we found no evidence of imbalance across
exposure groups with respect to gender, smoking status, and age. To test
for covariate balance across treatments, we perform a MANOVA using the
Wilks’ statistic (Wilks, 1932), as defined in Section 4.2. Figure 2 shows the
covariate distribution for gender, smoking status and age after trimming. We
see that gender and smoking status are still imbalanced even after trimming,
and hence were adjusted for in the linear regression that includes covariates
(this is true for all “designs”).
The first dataset that resulted in no evidence of covariate imbalance con-
sisted of 169 observations, and the new treatment counts are presented in
Table 5. After removing units with missing covariate values for the regres-
sion that adjusts for income and ethnicity, we had 158 units. Note that while
gender, smoking status, and age are our first tiers of covariates, ethnicity and
income constitutes the second tiers. In practice, balancing a large set of co-
variates is not always possible. Therefore, choosing the most important ones
should be done using subject matter knowledge. We see here that the num-
ber of units has been drastically reduced in our attempt to achieve covariate
balance, a major challenge in this setting. In fact, one of the treatment
groups only has three observations, a very small number. See Appendix D.3
for full analysis results.
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Factor Levels Number of Obs.
beta-Hex Hept Epox Mirex p,p’-DDT Original Trimmed
z2 +-1 -+1 -+1 -+1 12 6
z3 -+1 +-1 -+1 -+1 70 22
z5 -+1 -+1 +-1 -+1 291 102
z8 +-1 +-1 +-1 -+1 54 10
z9 -+1 -+1 -+1 +-1 21 8
z12 +-1 +-1 -+1 +-1 19 10
z14 +-1 -+1 +-1 +-1 19 3
z15 -+1 +-1 +-1 +-1 37 8
g∗1 g
∗
2 g
∗
3 g
∗
4 523 169
Table 5: Counts of observations for each treatment combination of the pes-
ticides with farmers removed for the fractional factorial design, before and
after trimming.
5.4 Results comparison across different conceptualized
experiments and statistical approaches
Figure 3 shows a comparison of the regression estimates of the main effects
across designs and statistical analyses. To compare the different methods
we present univariate analyses, that is we utilize individual tests for each
main effect rather than joint tests, for better illustration of the different
methods. Recall that the standard Fisherian and Neymanian point esti-
mates are the unadjusted regression estimates multiplied by two. The bars
show two standard errors above and below the estimate calculated by the
usual ordinary least squares as the Neymanian variance estimates are not
available for the full factorial design. In practice, adjustment for multiple
comparisons should be considered. All methods and designs seem to agree
on the positive effect of heptachlor epoxide and the negative effect of mirex
on BMI. Although the full factorial estimates generally agree with the es-
timates of the two fractional factorial designs, differences in estimates of
beta-Hexachlorocyclohexane (Beta-Hex) and p,p’-DDT may be due to the
aliasing of the three-factor interactions with the main effects. However, it
is also plausible that we have reduced our data in the fractional design to a
group with different average main effects than in the full data set.
Figure 4 shows a comparison of the significance of these estimates. The
Fisher p-value is the p-value for the test of no effects of any pesticides, based
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on effect estimates for a given pesticide, which is suggested as a screening
stage in Espinosa et al. (2016). We obtained low p-values for the main effect
of mirex on BMI across all methods and designs. However, the p-values
disagree for the other pesticides, especially the p-values testing the effects
of p,p’-DDT and beta-Hexachlorocyclohexane. Note that the HC2/Neyman
p-value is the significance based on the HC2 variance estimate (or Neyman
variance estimate as we have shown this estimator to be equivalent in settings
with no covariates) and the Normal approximation. This p-value was only
calculated for the regression analysis without covariates and was unavailable
for the full factorial model due to limited data.
5.5 Discussion of data illustration
We have performed a data illustration to show the benefits and challenges of
using our method and working with observational data with multiple treat-
ments in general. Here we outline some of the problems that we ran into,
that could be improved in future analyses, and also some of our findings. It
is important to note that simplifications were made in the statistical analy-
ses to focus on illustrating how researchers can capitalize on using fractional
factorial designs to estimate the main and interactive effects of multiple treat-
ments in observational studies. For instance, we are aware that multiply im-
puting the missing data would have been more appropriate to provide valid
estimates and inferences in the original study population. However, for sim-
plicity we focused on the complete-case observations. We additionally did
not adjust for all important hypothetical covariates, such as diet. Because
BMI is a ratio, its distribution tends to have heavy tails. We log-transformed
BMI but heavy-tailed distributions could have been considered. Trimming
helps mitigate bias but greatly reduced our sample size, potentially leading
to decreased power and precision.
For p,p’-DDT, the full factorial design resulted in a lower p-value than the
other designs, which could be an issue of aliased interactions watering down
the effect in the fractional design. It could also have occurred because the
populations are different in these two designs. For beta-Hexachlorocyclohexane,
the covariate balance adjusted fractional factorial design differs, leading to
a lower p-value for the association of beta-Hexachlorocyclohexane with BMI
compared to the other designs. We are more inclined to trust the balanced
design as this should have reduced bias. This result may indicate that there
was some confounding that made the effect appear less significant before
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trimming. In fact, the stark contrast between the unbalanced and balanced
fractional design suggests that confounding may be to blame. Alternatively,
by trimming we may have reduced our sample to a subpopulation where
beta-Hexachlorocyclohexane has a larger effect on BMI than the rest of the
population.
6 Discussion
In this paper, we have proposed to embed observational studies with multi-
ple treatments in fractional factorial hypothetical experiments. This type of
design is useful in settings with many treatments, especially when some treat-
ment combinations have few or no observations and the aliasing assumptions
are plausible. Once we recreate a factorial or fractional factorial experiment
in the design phase, we can use standard methods, extended as in Sections 2
and 3, to estimate causal effects of interest. We first reviewed the basic
setup for factorial and fractional factorial designs. Our main contribution
is in extending these ideas for use in observational studies. This includes
discussion of tests that can be performed before the full analysis. We have
also discussed covariate balance complications that may arise when dealing
with multiple non-randomized treatments in practice.
We illustrated these methods on a data set with pesticide exposure and
BMI. This helped to exemplify the uses of our new methodology as well as
identify challenges that occur when working with observational data with
multiple treatments. It is important to note that using the small subset of
the NHANES dataset, we do not intend to provide policy recommendations
on pesticide use. In the general population, organochlorine pesticide expo-
sure primarily occurs through diet (excluding those with farm-related jobs),
particularly eating foods such as dairy products and fatty fish (Centers for
Disease Control and Prevention (CDC), 2009). Without further adjustments
for diet, we are not be able to disentangle the causal effect of diet and pesti-
cides. For instance, in our study individuals are likely to have been exposed
to mirex largely through fish consumption (Agency for Toxic Substances and
Disease Registry [ATSDR], 1995). Further studies could investigate BMI dif-
ferences in a group of fish consumers with high level of mirex and a “similar”
group of fish consumers with low level of mirex, where similar is with respect
of important confounding variables. Indeed, it could be that eating fish cause
individuals to have both high levels of mirex and also lower BMI.
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We have given a short overview of factorial and fractional factorial de-
signs, as well as some other designs, in the potential outcomes framework.
However, there are many aspects of these designs and classic analysis tech-
niques that we did not cover. For instance, there are many nonregular de-
sign types, such as Plackett-Burman designs, that we could have explored
more. Practitioners may also use variable selection and the principle of ef-
fect heredity to select their model for estimating factorial effects, including
via Bayesian variable selection. See Wu and Hamada (2000) for more details
on these methods from a more classical experimental design perspective.
We see many avenues of future exploration connected to our approach.
For instance, coupling fractional factorial designs with a Bayesian frame-
work would provide more statistical tools and would potentially offer differ-
ent methodology for dealing with missing data. Additionally, development
of balancing techniques for fractional factorial designs with many treatment
combinations should be an area of future exploration. A particular challenge
is that as we increase the number of treatment combinations and therefore
treatment groups, matching becomes more and more difficult due to the
increased dimensionality. This work can also related to random allocation
designs (Dempster, 1960, 1961), in which randomness of the design is incor-
porated.
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Figure 1: Comparing covariates across treatment combinations in the 24−1
fractional factorial design. Text labels give number of observations per group.
For age, individuals with “>= 85 years of age” were set to 85 on the graph.
Note that all individuals older than 85 were dropped in the covariate balance
stage.
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fractional factorial design after trimming. Text labels give number of obser-
vations per group.
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A Variance derivations
A.1 Variance and covariance of observed mean poten-
tial outcomes
This section gives results for the building blocks necessary to obtain results
such as Equation 1 and Equation 4. We start with the variance and co-
variance of the treatment indicators, which give results related to those in
Lemma 1 and 2 of Dasgupta et al. (2015). For i 6= k,
Cov (Wi(zj),Wk(zj)) = E [Wi(zj)Wk(zj)]− E [Wi(zj)]E [Wk(zj)]
= P (Wk(zh) = 1|Wi(zj) = 1)P (Wi(zj) = 1)−
n2j
n2
=
nj
n
nj − 1
n− 1 −
n2j
n2
=
nj(nj − n)
n2(n− 1) .
For i 6= k and j 6= h,
Cov (Wi(zj),Wk(zh)) = E [Wi(zj)Wk(zh)]− E [Wi(zj)]E [Wk(zh)]
= P (Wk(zh) = 1|Wi(zj) = 1)P (Wi(zj) = 1)− njnh
n2
=
nh
n− 1
nj
n
− njnh
n2
=
njnh
n2(n− 1) .
These results can be used directly to get the variance of Y¯ obs(zj) and
covariance of Y¯ obs(zj) and Y¯
obs(zh). See Lu (2016b) for proof.
A.2 Variance for fractional factorial design
This section gives details on the derivation of the variance of our estimators
of factorial effects under a fractional factorial design, as given in Equation 4.
The proofs here are similar to those given in Dasgupta et al. (2015) and Lu
(2016b). We first breakdown S˜2k in the same way that Dasgupta et al. (2015)
and Lu (2016b) broke down S2k , to show that we obtain similar results for
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the fractional case as the full factorial. Let g∗kj be the jth element of vector
g∗k.
S˜2k =
1
n− 1
n∑
i=1
(τ˜i(k)− τ˜(k))2
=
1
n− 1
n∑
i=1
2−2(K−p−1)
(
g∗Tk Y∗i − g∗Tk Y¯∗
)2
=
1
n− 12
−2(K−p−1)
n∑
i=1
(
J ′∑
j=1
g∗kj
(
Yi(z
∗
j )− Y¯ (z∗j )
))2
= 2−2(K−p−1)
[
J ′∑
j=1
g∗2kjS
2(z∗j ) +
∑
j
∑
h6=j
g∗kjg
∗
khS
2(z∗j , z
∗
h)
]
Now we find the variance of τ̂ ∗(k) in a proof analogous to that given
for balanced factorial designs in Dasgupta et al. (2015) and for unbalanced
factorial designs in Lu (2016b).
Var (τ̂ ∗(k)) =
1
22(K−p−1)
g∗Tk Var
(
Y¯ obs∗
)
g∗k
=
1
22(K−p−1)
[
J ′∑
j=1
g∗2kjVar
(
Y¯ obs(z∗j )
)
+
∑
j
∑
h6=j
g∗kjg
∗
khCov
(
Y¯ obs(z∗j ), Y¯
obs(z∗h)
)]
=
1
22(K−p−1)
[
J ′∑
j=1
n− n∗j
nn∗j
S2(z∗j )−
1
n
∑
j
∑
h6=j
g∗kjg
∗
khS
2(z∗j , z
∗
h)
]
=
1
22(K−p−1)
J ′∑
j=1
(
n− n∗j
nn∗j
+
1
n
)
S2(z∗j )−
1
n
S˜2k
=
1
22(K−p−1)
J ′∑
j=1
1
n∗j
S2(z∗j )−
1
n
S˜2k
A.3 Covariance for fractional factorial design
In this section we find the covariance between two factorial effect estimates
from a fractional factorial design. We again closely follow proofs from Das-
gupta et al. (2015) and Lu (2016b), showing that the same processes work
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in the fractional factorial case. First we breakdown S˜2k,k′ .
S˜2k,k′ =
1
n− 1
n∑
i=1
(τ˜i(k)− τ˜(k)) (τ˜i(k′)− τ˜(k′))
=
1
n− 12
−2(K−p−1)
n∑
i=1
(
g∗Tk Y∗i − g∗Tk Y¯∗
) (
g∗Tk′ Y∗i − g∗Tk′ Y¯∗
)
=
1
n− 12
−2(K−p−1)
n∑
i=1
(
J ′∑
j=1
g∗kj(Yi(z
∗
j )− Y¯ (z∗j ))
)(
J ′∑
j=1
g∗k′j(Yi(z
∗
j )− Y¯ (z∗j ))
)
= 2−2(K−p−1)
(
J ′∑
j=1
g∗kjg
∗
k′jS
2(z∗j ) +
∑
j
∑
h6=j
g∗kjg
∗
k′hS
2(z∗j , z
∗
h)
)
Cov (τ̂ ∗(k), τ̂ ∗(k′)) = 2−2(K−p−1)g∗Tk Var
(
Y¯ obs∗
)
g∗k′
=
1
22(K−p−1)
[ J ′∑
j=1
g∗kjgk′jVar
(
Y¯ obs(z∗j )
)
+
∑
j
∑
h6=j
g∗kjg
∗
k′hCov
(
Y¯ obs(z∗j ), Y¯
obs(z∗h)
) ]
=
1
22(K−p−1)
[
J ′∑
j=1
n− n∗j
nn∗j
g∗kjgk′jS
2(z∗j )−
1
n
∑
j
∑
h6=j
g∗kjg
∗
k′hS
2(z∗j , z
∗
h)
]
=
1
22(K−p−1)
[
J ′∑
j=1
(
n− n∗j
nn∗j
+
1
n
)
g∗kjg
∗
k′hS
2(z∗j )
]
− 1
n
S˜2k,k′
=
1
22(K−p−1)
[
J ′∑
j=1
1
n∗j
g∗kjg
∗
k′hS
2(z∗j )
]
− 1
n
S˜2k,k′
=
1
22(K−p−1)
 ∑
j:g∗kj=g
∗
k′j
1
n∗j
S2(z∗j )−
∑
j:g∗kj 6=g∗k′j
1
n∗j
S2(z∗j )
− 1
n
S˜2k,k′
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B Relating linear regression estimators to Ney-
man estimators in the fractional factorial
design
This section gives a brief overview of a proof that the linear regression point
estimates are the same as the Neymanian estimates for the fractional factorial
design. For proofs of these results for the full factorial design, see Lu (2016b).
The linear regression coefficient estimate is
βˆ = (XTX)−1XTY obs,
whereX is a n×2K−p matrix whose columns correspond to first an intercept,
then include the main effects, then the second order interactions not aliased
with the main effects, and so on such that no two columns are aliased. For
instance, for the 23−1 design laid out in Section 3,X would be a design matrix
with a first column of 1’s and the rest of the columns corresponding to levels
of the first, second, and third factor. No interactions would be included in this
example because each of the two factor interactions is aliased with a main
effect and the three factor interaction is aliased with the intercept, which
are all already included in the model. Thus the design looks a bit like the
columns g∗1, g
∗
2, and g
∗
3 of Table 2, but with repeated rows for each of the units
assigned to the same treatment combination. We need (XTX)−1XTX = I.
Denote B = (XTX)−1XT .
(BX)ij = bi·fj
where bi· is the ith row of B and fj is the jth column of XT . Using notation
from Section 4.3, let h∗j be the jth row of G
∗T which is an expanded version
of z∗j which includes elements for interactions and the intercept. Then fji,
the ith element of fj is h
∗
kj, the jth element of h
∗
k, where k is the treatment
combination for the ith individual. It must be true that (BX)ii = 1 and
(BX)ij = 0 for i 6= j. Consider letting the ith row of B be bi· = 12K−p (n˜−1 ◦
fi)
T where n˜−1 is the vector whose ith entry is 1
n∗j
where j is number of the
treatment combination that the ith unit is assigned to (j =
∑J ′
k=1 kWi(zk)).
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Then we have
(BX)kk = bk·fk
=
1
2K−p
(n˜−1 ◦ fk)Tfk
=
1
2K−p
(n˜−1)Tfk ◦ fk
=
1
2K−p
J ′∑
j=1
∑
i:Wi(z∗j )=1
1
n∗j
=
1
J ′
∑
j
1
= 1.
For k 6= j
(BX)kj = bk·fj
=
1
2K−p
(n˜−1 ◦ fk)Tfj
=
1
2K−p
(n˜−1)Tfk ◦ fj
=
1
2K−p
J ′∑
s=1
1
n∗s
∑
i:Wi(h∗s)=1
h∗skh
∗
sj
=
1
2K−p
 ∑
s:h∗sk=h
∗
sj
1−
∑
s:h∗sk 6=h∗sj
1

= 0.
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So the kth row of B is 1
2K−p (n˜
−1 ◦ fk)T . This means that
βˆk =
(
(XTX)−1XTY obs
)
k
= (
1
2K−p
n˜−1 ◦ fk)TY obs
=
1
2K−p
J ′∑
j=1
1
n∗j
∑
i:Wi(z∗j )=1
h∗jkYi(h
∗
j)
=
1
2K−p
J ′∑
j=1
h∗jkY
obs(z∗j )
=
1
2K−p
g∗Tk Y¯
obs
=
1
2
τ̂ ∗(k).
So, indeed, the linear regression estimates are one half of the factorial effects.
Now let us consider the HC2 variance estimator. It has the form (MacK-
innon and White, 1985)
V̂ arHC2(β̂) =
(
XTX
)−1
XT Ω̂X
(
XTX
)−1
where Ω̂ = diag
(
eˆi
1−hii
)
with eˆi being the residual for observation i and hii
being the ii value of the hat matrix, X
(
XTX
)−1
XT . For discussion of this
estimators in the single treatment case and the factorial case, see Samii and
Aronow (2012) and Lu (2016b), respectively. We use similar ideas to those
papers in the arguments below.
If unit i was assigned to treatment z∗k then the ith column of
(
XTX
)−1
XT
is b·i = 12K−p
1
n∗k
h∗Tk . We have(
X
(
XTX
)−1
XT
)
ii
=
1
2K−p
1
n∗k
h∗kh
∗T
k
=
1
2K−p
1
n∗k
2K−p
=
1
n∗k
.
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So then 1− hii = 1− 1n∗k =
n∗k−1
n∗k
. This in turn means that
eˆi
1− hii =
n∗k
(
Y obsi − Y¯ obs(z∗k)
)2
n∗k − 1
Now we can solve for the whole expression of V̂ arHC2(β̂). We focus on
the diagonal entries.(
V̂ arHC2(β̂)
)
kk
=
((
XTX
)−1
XTdiag
(
eˆj
1− hjj
))
i·
(
X
(
XTX
)−1)
·i
= (
1
2K−p
n˜−1 ◦ fk)Tdiag
(
eˆj
1− hjj
)
(
1
2K−p
n˜−1 ◦ fk)
= (
1
2K−p
s1 ◦ fk)T ( 1
2K−p
n˜−1 ◦ fk)
= (
1
2K−p
s1)
T (
1
2K−p
n˜−1 ◦ fk ◦ fk)
=
1
22(K−p)
(s1)
T n˜−1
=
1
22(K−p)
J ′∑
j=1
1
n∗j
∑
i:Wi(z∗j )=1
(
Yi(z
∗
j )− Yi(z∗j )
)2
n∗j − 1
=
1
22(K−p)
∑
j
1
n∗j
s2(z∗j )
where s1 is the vector of whose ith entry, given entry i is assigned treatment
combination z∗k, is
(Yi(z∗k)−Yi(z∗k))
2
n∗k−1
. Thus, we have that
(
V̂ arHC2(β̂)
)
kk
is 1/4
times the Neyman style variance estimator.
C Incomplete factorial Designs
C.1 Inference
This section discusses alternative incomplete factorial designs that one might
use. See Byar et al. (1993) for more discussion on incomplete factorial de-
signs. This discussion also applies more generally to recreating fractional
designs in observational settings where we are using a subset of treatment
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combinations present in the data. We follow the same outline as proofs from
Section A.2. In these incomplete factorial designs, for each main effect or
other estimand of interest, we define a new experimental design tailored to
estimating that effect. When this is done, we then analyze the data as if
the treatment groups within the new design are the only possible treatment
groups.
First we need to introduce some notation. Let g˙j be the same as gj but
with zero elements corresponding to treatment combinations that are not
included in the particular design in use. Let 2m treatment groups be used in
the design, with half assigned to the +1 level of factor one and half assigned
to the −1 level of factor one. Let τ˙(k) = 2−(m−1)g˙Tk Y¯ . Then we can do a
breakdown S˙2k , defined in the first line below:
S˙2k =
1
n− 1
n∑
i=1
(τ˙i(k)− τ˙(k))2
=
1
n− 1
n∑
i=1
2−2(m−1)
(
g˙Tk Yi − g˙Tk Y¯
)2
=
1
n− 12
−2(m−1)
n∑
i=1
(
J ′∑
j=1
g˙kj
(
Yi(zj)− Y¯ (zj)
))2
= 2−2(m−1)
[
J∑
j=1
g˙2kjS
2(zj) +
∑
j
∑
h6=j
g˙kj g˙khS
2(zj, zh)
]
.
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Then we have
Var
(̂˙τ(k)) = 1
22(m−1)
g˙Tk Var
(
Y¯ obs
)
g∗k
=
1
22(K−p−1)
[
J∑
j=1
g˙2kjVar
(
Y¯ obs(zj)
)
+
∑
j
∑
h6=j
g˙kj g˙khCov
(
Y¯ obs(zj), Y¯
obs(zh)
)]
=
1
22(K−p−1)
[
J∑
j=1
g˙2kj
n− nj
nnj
S2(zj)− 1
n
∑
j
∑
h6=j
g˙kj g˙khS
2(zj, zh)
]
=
1
22(K−p−1)
J∑
j=1
g˙2kj
(
n− nj
nnj
+
1
n
)
S2(zj)− 1
n
S˙2k
=
1
22(K−p−1)
J∑
j=1
g˙2kj
1
nj
S2(zj)− 1
n
S˙2k .
An important note is that in terms of estimation of this variance, whether
we analyze the data as if the treatment levels in this design are the only
possible treatment combinations or if we keep the assumption that units
can be assigned to any possible treatment combinations (which aids in the
interpretation and inference), the variance estimator will be the same. This
is because we can only estimate the first term in this expression which only
involves the specific treatment levels in this design.
C.2 Variance of estimators for incomplete factorial de-
signs
Consider comparing two designs. The first involves J∗ treatment groups and
the second involves J˜ < J∗ treatment groups. Let’s assume that for all
treatment groups nj = c and S
2(zj) = S
2. That is, all treatment groups
are the same size and effects are additive so that the variance of potential
outcomes in each treatment group is the same.
Then for the first design we have variance of
1
J∗2
J∗∑
j
1
nj
S2(zj)− 1
n
S2k =
1
cJ∗
S2.
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For the second design we have
1
J˜2
J˜∑
j
1
nj
S2(zj)− 1
n
S2k =
1
cJ˜
S2.
So in this setting the design with more treatment groups will have lower
variance, which is intuitive. However, in general if we do not have the ad-
ditive treatment effect assumption, it is possible that the design with more
treatment groups includes treatment groups that are much more variable and
therefore the variance of the estimator is actually larger.
C.3 Regression with missing levels
This section discusses what will result from a standard regression interacting
all factors when not all treatment combinations are observed in the data.
If the dataset is missing m treatment combinations, then the regression
will be able to estimate the first 2K −m effects (including interactions) that
are not aliased and the rest will be removed due to collinearity of the matrix
columns. Then for each effect, there will be some aliasing structure imposed
but the same “design” will not necessarily be used for each factor.
To explore this scenario more, let’s take the specific example of three
factors where we only observe five of the eight treatment combinations. For
simplicity let there be one observation for each treatment combination and
let the model matrix be as follows:
X =

1 −1 −1 +1 +1
1 −1 +1 −1 −1
1 +1 −1 −1 −1
1 +1 +1 +1 +1
1 −1 −1 −1 +1
 .
The first column corresponds to the intercept, the second through fourth
columns give the levels for the three factors, and the fifth column corresponds
to the interaction between the first and second factor. Note that the first
four rows correspond to a 23−1 design, so it is possible to recreate that design
here.
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Now through basic linear algebra,
(
XTX
)−1
XT =

0.25 0.25 0.25 0.25 0
−0.25 −0.25 0.25 0.25 0
−0.25 0.25 −0.25 0.25 0
0.5 0 0 0 −0.5
−0.25 −0.25 −0.25 0.25 0.5
 .
Recalling that βˆ =
(
XTX
)−1
XTY obs, the first three columns correspond to
estimates we would get using the fractional factorial design using the defining
relation I = 123. The last two estimates, for factor 3 and the interaction
between factors 1 and 2, have a different aliasing structure. In particular,
the aliasing on factor 3 is similar to aliasing structures in Section 4.3 and we
can find that factor 3 will be aliased with the two-factor interactions 13 and
23 as well as the three-factor interaction.
D Data illustration
This section gives some additional descriptors for the data.
Figure 5 shows that the proportion of farmers is different across the eight
treatments of the hypothetical fractional factorial experiment defined in Sec-
tion 5.3.2.
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Figure 5: Comparing number of farmers across factor levels in the 24−1 frac-
tional factorial design. Text labels give number of observations per group.
Figure 6 shows the correlations between the levels of the different pesti-
cides.
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For each design, we explore regression (both saturated, i.e. with all in-
teractions among factors, and unsaturated, i.e. without interactions among
factors), regression with covariates (both saturated and unsaturated for the
factors), and Fisher tests for significance of effects. We also include the HC2
standard error estimate for the saturated model without covariates, where
it is equivalent to the Neyman estimator, when possible. Note that all re-
gression outputs are using log BMI as output. An important note is that
individuals with missing values, either for factor levels, treatment levels, or
covariates where they are used, were removed. This action likely changes
the types of individuals within the analysis and therefore the generalizability
of the results. However, as this is intended as simply an illustration of the
methods and not as a full analysis to draw substantive conclusions from, this
simple model suffices to allow us to continue with the analysis.
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Figure 6: Plot of correlations between pesticide levels.
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D.1 Full factorial design
D.1.1 Full factorial: Regression analysis
We start by ignoring our limited data and use a full 24 factorial approach.
Table 6 shows an analysis with all factors and no interactions. Table 7 shows
the saturated model with all interactions. Note that the individual who
received treatment combination (−1, 1, 1,−1) has leverage 1 because they are
the only individual with that treatment combination. Because of this data
limitation, estimating variance using the HC2/Neyman variance estimator is
not possible for the saturated case. Also note that in the saturated model,
the variance estimates given in the linear model summary are all the same.
This will be true of Neyman variance estimates too, since they are the same
for each factorial effect estimators. Note the changes in significance of the
estimator and even a change in sign for the estimate of beta-Hex going from
the model with just main effects to the saturated model.
Table 6: All-pesticide model
Estimate Std. Error t value Pr(>|t|)
(Intercept) 3.289 0.008 430.426 0.000
beta-Hex -0.001 0.008 -0.067 0.946
Hept Epox 0.062 0.007 9.201 0.000
Mirex -0.027 0.006 -4.709 0.000
p,p’-DDT 0.020 0.008 2.595 0.010
D.1.2 Full factorial: Regression analysis adjusting for covariates
This section gives the analysis of the full factorial design, adjusting for the
covariates of income, ethnicity, gender and smoking status as linear factors in
the model. For simplicity, we remove all individuals who had missing values
for income or ethnicity, and assume that those values are missing at random.
This resulted in 75 units being removed. In practice one should instead use
multiple imputation to account for the missing values. One individual refused
to give income (the only such individual) and so was removed. This did not
affect the analysis. The unit assigned to the unique treatment combination,
necessarily had leverage one in the saturated model. This baseline level for
income in the analysis was “$0 to $4,999.” Baseline for ethnicity is “Mexican
American.”
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Table 7: Saturated model
Estimate Std. Error t value Pr(>|t|)
(Intercept) 3.276 0.015 224.028 0.000
beta-Hex 0.010 0.015 0.713 0.476
Hept Epox 0.038 0.015 2.605 0.009
Mirex -0.050 0.015 -3.445 0.001
p,p’-DDT 0.025 0.015 1.699 0.090
beta-Hex:Hept Epox 0.012 0.015 0.830 0.407
beta-Hex:Mirex 0.007 0.015 0.456 0.649
Hept Epox:Mirex -0.037 0.015 -2.515 0.012
beta-Hex:p,p’-DDT -0.008 0.015 -0.569 0.569
Hept Epox:p,p’-DDT 0.011 0.015 0.779 0.436
Mirex:p,p’-DDT 0.015 0.015 1.016 0.310
beta-Hex:Hept Epox:Mirex 0.026 0.015 1.790 0.074
beta-Hex:Hept Epox:p,p’-DDT 0.007 0.015 0.500 0.617
beta-Hex:Mirex:p,p’-DDT 0.003 0.015 0.179 0.858
Hept Epox:Mirex:p,p’-DDT 0.014 0.015 0.969 0.333
beta-Hex:Hept Epox:Mirex:p,p’-DDT -0.004 0.015 -0.257 0.797
D.1.3 Full factorial: Fisherian analysis
We assume the sharp null hypothesis of zero individual factorial effects, for
all factors and interactions. This means that imputed missing potential out-
comes for different assignments are just the observed potential outcomes.
We do the imputation, or effectively rearrange the assignment vector, 1000
times.
As we can see from the plots and confirmed by calculation, only heptachlor
epoxide (Hept Epox) and mirex appear to be significantly different from zero
at the 0.05 level. We only examine the main effects here but could further
consider interactions.
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Figure 7: Basic diagnostics plot for the full model given in Table 6.
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Figure 8: Basic diagnostics plot for the saturated model given in Table 7.
Note that the individual with unique treatment combination had leverage 1.
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Table 8: All-pesticide model
Estimate Std. Error t value Pr(>|t|)
(Intercept) 3.302 0.047 70.165 0.000
beta-Hex 0.001 0.008 0.070 0.944
Hept Epox 0.064 0.007 9.413 0.000
Mirex -0.031 0.006 -5.240 0.000
p,p’-DDT 0.019 0.008 2.452 0.014
Income:$ 5,000 to $ 9,999 -0.005 0.051 -0.108 0.914
Income:$10,000 to $14,999 -0.016 0.049 -0.332 0.740
Income:$15,000 to $19,999 0.022 0.049 0.445 0.657
Income:$20,000 to $24,999 0.011 0.048 0.228 0.820
Income:$25,000 to $34,999 -0.014 0.047 -0.287 0.774
Income:$35,000 to $44,999 -0.002 0.048 -0.037 0.971
Income:$45,000 to $54,999 0.000 0.049 0.002 0.999
Income:$55,000 to $64,999 0.000 0.050 0.009 0.993
Income:$65,000 to $74,999 0.011 0.052 0.206 0.837
Income:$75,000 and Over -0.004 0.046 -0.091 0.928
Income:Don’t know -0.168 0.142 -1.188 0.235
Income:Over $20,000 0.033 0.081 0.404 0.686
Ethnicity:Non-Hispanic Black 0.068 0.019 3.612 0.000
Ethnicity:Non-Hispanic White -0.023 0.015 -1.514 0.130
Ethnicity:Other Hispanic -0.022 0.033 -0.678 0.498
Ethnicity:Other Race
- Including Multi-Racial
-0.055 0.029 -1.912 0.056
Gender:Male -0.005 0.012 -0.405 0.686
Smoker: Yes -0.011 0.011 -0.930 0.353
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Table 9: Saturated model
Estimate Std. Error t value Pr(>|t|)
(Intercept) 3.291 0.049 67.583 0.000
beta-Hex 0.011 0.015 0.766 0.444
Hept Epox 0.044 0.015 3.047 0.002
Mirex -0.054 0.015 -3.698 0.000
p,p’-DDT 0.025 0.014 1.700 0.089
beta-Hex:Hept Epox 0.011 0.014 0.734 0.463
beta-Hex:Mirex 0.003 0.014 0.218 0.828
Hept Epox:Mirex -0.039 0.015 -2.651 0.008
beta-Hex:p,p’-DDT -0.011 0.015 -0.724 0.469
Hept Epox:p,p’-DDT 0.009 0.015 0.639 0.523
Mirex:p,p’-DDT 0.015 0.014 1.014 0.311
beta-Hex:Hept Epox:Mirex 0.028 0.014 1.927 0.054
beta-Hex:Hept Epox:p,p’-DDT 0.004 0.015 0.270 0.787
beta-Hex:Mirex:p,p’-DDT 0.005 0.015 0.371 0.711
Hept Epox:Mirex:p,p’-DDT 0.011 0.015 0.773 0.440
beta-Hex:Hept Epox:Mirex:p,p’-DDT –0.002 0.014 -0.114 0.909
Income:$ 5,000 to $ 9,999 0.003 0.050 0.060 0.952
Income:$10,000 to $14,999 -0.016 0.048 -0.329 0.743
Income:$15,000 to $19,999 0.028 0.049 0.576 0.565
Income:$20,000 to $24,999 0.007 0.048 0.136 0.891
Income:$25,000 to $34,999 -0.011 0.047 -0.232 0.816
Income:$35,000 to $44,999 0.001 0.048 0.024 0.980
Income:$45,000 to $54,999 -0.001 0.049 -0.011 0.991
Income:$55,000 to $64,999 0.001 0.050 0.010 0.992
Income:$65,000 to $74,999 0.010 0.052 0.196 0.844
Income:$75,000 and Over -0.003 0.046 -0.073 0.942
Income:Don’t know -0.159 0.141 -1.127 0.260
Income:Over $20,000 0.039 0.081 0.488 0.626
Ethnicity:Non-Hispanic Black 0.067 0.019 3.571 0.000
Ethnicity:Non-Hispanic White -0.023 0.015 -1.505 0.133
Ethnicity:Other Hispanic -0.026 0.033 -0.792 0.429
Ethnicity:Other Race
- Including Multi-Racial
-0.057 0.029 -1.971 0.049
Gender:Male -0.002 0.012 -0.133 0.894
Smoker:Yes -0.014 0.011 -1.215 0.225
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Figure 9: Basic diagnostics plot for the full model given in Table 8.
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Figure 10: Basic diagnostics plot for the saturated model given in Table 9.
Note that the individual with unique treatment combination had leverage 1.
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Figure 11: Plots of simulated treatment effects estimated. Observed treat-
ment effect estimates plotted in red.
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D.2 Fractional factorial design
D.2.1 Fractional factorial: Regression analysis
This section gives the analysis of the fractional factorial design as is, using
regression. Note that we remove farmers again, leaving 523 observations.
Table 10 shows an analysis with all factors and no interactions. Table 11
shows the saturated model with all interactions. These results generally
align with the full factorial analysis, in terms of sign and significance of
terms. Figures 12 and 13 show basic diagnostic plots for the model with all
main effects and the saturated model. Note again that it makes sense that
the standard errors estimates are the same for all estimates in the saturated
model because the same groups are being used to calculate them.
Table 10: All-pesticide model
Estimate Std. Error t value Pr(>|t|)
(Intercept) 3.283 0.013 257.366 0.000
beta-Hex 0.007 0.012 0.570 0.569
Hept Epox 0.046 0.011 4.232 0.000
Mirex -0.053 0.011 -4.673 0.000
p,p’-DDT 0.007 0.011 0.578 0.563
Table 11: Saturated model
Estimate Std. Error HC2 t value Pr(>|t|)
(Intercept) 3.279 0.013 0.013 249.551 0.000
beta-Hex -0.004 0.013 0.013 -0.284 0.776
Hept Epox 0.035 0.013 0.013 2.699 0.007
Mirex -0.058 0.013 0.013 -4.389 0.000
p,p’-DDT -0.001 0.013 0.013 -0.102 0.919
beta-Hex:Hept Epox -0.003 0.013 0.013 -0.207 0.836
beta-Hex:Mirex -0.005 0.013 0.013 -0.359 0.720
Hept Epox:Mirex -0.028 0.013 0.013 -2.165 0.031
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Figure 12: Basic diagnostics plot for the saturated model given in Table 10.
D.2.2 Fractional factorial: Regression analysis adjusting for co-
variates
This section gives the analysis of the fractional factorial design, adjusting
for the covariates of income, ethnicity, gender and smoking status as linear
factors in the model. We again removed units who were missing values for
income or race, reducing the sample size by 34. One unit replied “Don’t
know” for income so this unit was removed. This did not affect the analysis.
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Figure 13: Basic diagnostics plot for the saturated model given in Table 11.
D.2.3 Fractional factorial: Fisherian analysis
Once again, only heptachlor epoxide (Hept Ex) and mirex appear to be
significantly different than zero at the 0.05 level.
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Table 12: All-pesticide model
Estimate Std. Error t value Pr(>|t|)
(Intercept) 3.332 0.074 44.845 0.000
beta-Hex 0.008 0.012 0.682 0.495
Hept Epox 0.047 0.011 4.304 0.000
Mirex -0.052 0.012 -4.464 0.000
p,p’-DDT 0.006 0.011 0.487 0.626
Income:$ 5,000 to $ 9,999 -0.079 0.083 -0.949 0.343
Income:$10,000 to $14,999 -0.066 0.077 -0.867 0.387
Income:$15,000 to $19,999 -0.060 0.078 -0.775 0.439
Income:$20,000 to $24,999 -0.031 0.077 -0.398 0.691
Income:$25,000 to $34,999 -0.027 0.076 -0.353 0.724
Income:$35,000 to $44,999 -0.014 0.076 -0.181 0.856
Income:$45,000 to $54,999 -0.036 0.076 -0.470 0.639
Income:$55,000 to $64,999 -0.001 0.080 -0.017 0.986
Income:$65,000 to $74,999 -0.017 0.080 -0.216 0.829
Income:$75,000 and Over -0.048 0.073 -0.660 0.510
Income:Over $20,000 -0.022 0.118 -0.190 0.849
Ethnicity:Non-Hispanic Black 0.064 0.030 2.149 0.032
Ethnicity:Non-Hispanic White -0.015 0.023 -0.667 0.505
Ethnicity:Other Hispanic -0.025 0.051 -0.502 0.616
Ethnicity:Other Race
- Including Multi-Racial
-0.040 0.043 -0.930 0.353
Gender:Male -0.000 0.019 -0.014 0.989
Smoker:Yes -0.016 0.018 -0.888 0.375
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Table 13: Saturated model
Estimate Std. Error t value Pr(>|t|)
(Intercept) 3.331 0.074 44.901 0.000
beta-Hex -0.001 0.014 -0.075 0.941
Hept Epox 0.037 0.013 2.794 0.005
Mirex -0.057 0.014 -4.212 0.000
p,p’-DDT -0.002 0.013 -0.113 0.910
beta-Hex:Hept Epox -0.005 0.013 -0.406 0.68
beta-Hex:Mirex -0.007 0.013 -0.545 0.586
Hept Epox:Mirex -0.027 0.013 -2.027 0.043
Income:$ 5,000 to $ 9,999 -0.086 0.083 -1.035 0.301
Income:$10,000 to $14,999 -0.076 0.077 -0.995 0.320
Income:$15,000 to $19,999 -0.064 0.077 -0.831 0.406
Income:$20,000 to $24,999 -0.045 0.077 -0.583 0.560
Income:$25,000 to $34,999 -0.031 0.076 -0.407 0.684
Income:$35,000 to $44,999 -0.023 0.076 -0.308 0.758
Income:$45,000 to $54,999 -0.046 0.076 -0.606 0.545
Income:$55,000 to $64,999 -0.013 0.080 -0.162 0.872
Income:$65,000 to $74,999 -0.027 0.080 -0.336 0.737
Income:$75,000 and Over -0.056 0.073 -0.759 0.448
Income:Over $20,000 -0.028 0.117 -0.238 0.812
Ethnicity:Non-Hispanic Black 0.071 0.030 2.360 0.019
Ethnicity:Non-Hispanic White -0.010 0.023 -0.451 0.652
Ethnicity:Other Hispanic -0.025 0.051 -0.494 0.621
Ethnicity:Other Race
- Including Multi-Racial
-0.041 0.042 -0.965 0.335
Gender:Male 0.003 0.019 0.139 0.889
Smoker:Yes -0.016 0.018 -0.882 0.378
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Figure 14: Basic diagnostics plot for the saturated model given in Table 12.
68
3.2 3.3 3.4 3.5
−
0.
6
−
0.
2
0.
0
0.
2
0.
4
0.
6
Predicted values
R
es
id
ua
ls
Residuals vs Fitted
327
146
406
−3 −2 −1 0 1 2 3
−
3
−
2
−
1
0
1
2
3
Theoretical Quantiles
St
d.
 d
ev
ia
nc
e 
re
si
d.
Normal Q−Q
327
39146
3.2 3.3 3.4 3.5
0.
0
0.
5
1.
0
1.
5
Predicted values
St
d.
 
de
vi
a
n
ce
 
re
si
d.
Scale−Location
327
39146
0.00 0.10 0.20
−
3
−
2
−
1
0
1
2
3
Leverage
St
d.
 P
e
a
rs
o
n
 r
e
si
d.
Cook's distance
Residuals vs Leverage
39
557
417
Figure 15: Basic diagnostics plot for the saturated model given in Table 13.
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Figure 16: Plots of simulated treatment effects estimated. Observed treat-
ment effect estimates plotted in red.
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D.3 Fractional factorial with covariate adjustment
169 units are retained after trimming.
D.3.1 Fractional factorial with covariate adjustment: Regression
analysis
This section gives the analysis of the fractional factorial design after trimming
to attain balance, using regression. Table 14 shows an analysis with all factors
and no interactions. Table 15 shows the saturated model with all interactions.
Figures 17 and 18 show basic diagnostic plots for the model with all main
effects and the saturated model.
Table 14: All-pesticide model
Estimate Std. Error t value Pr(>|t|)
(Intercept) 3.282 0.020 167.246 0.000
beta-Hex 0.041 0.020 2.053 0.042
Hept Epox 0.032 0.018 1.779 0.077
Mirex -0.075 0.018 -4.127 0.000
p,p’-DDT -0.006 0.020 -0.327 0.744
Table 15: Saturated model
Estimate Std. Error HC2 std t value Pr(>|t|)
(Intercept) 3.282 0.022 0.027 149.359 0.000
beta-Hex 0.038 0.022 0.027 1.719 0.088
Hept Epox 0.034 0.022 0.027 1.534 0.127
Mirex -0.077 0.022 0.027 -3.515 0.001
p,p’-DDT -0.008 0.022 0.027 -0.383 0.703
beta-Hex:Hept Epox -0.007 0.022 0.027 -0.299 0.765
beta-Hex:Mirex -0.003 0.022 0.027 -0.115 0.908
Hept Epox:Mirex -0.006 0.022 0.027 -0.264 0.792
D.3.2 Fractional factorial with covariate balance: Regression anal-
ysis adjusting for covariates
This section gives the analysis on the trimmed data set adjusting for ethnic-
ity, income, gender, and smoking status as linear factors in the regression.
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Figure 17: Basic diagnostics plot for the saturated model given in Table 14.
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Figure 18: Basic diagnostics plot for the saturated model given in Table 15.
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Figures 19 and 20 shows the balance across treatment groups for income and
ethnicity after trimming, indicating further need to adjust. We see from Fig-
ure 2 that gender and smoking also require further adjustment, even after
trimming.
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Figure 19: Balance of ethnicity in the different treatment groups after match-
ing.
Units who had missing values for income or ethnicity were removed, which
reduced the sample size by 9. We found that two units had unique income
values of “Over $20,000” and “0 to $4,999”. These units were removed. This
changes the baseline level for income in the analysis from “$0 to $4,999” to
“$5,000 to $9,999.”
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Figure 20: Balance of income in the different treatment groups after match-
ing.
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Figure 21: Basic diagnostics plot for the model given in Table 16.
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Table 16: All-pesticide model
Estimate Std. Error t value Pr(>|t|)
(Intercept) 3.292 0.086 38.110 0.000
beta-Hex 0.037 0.021 1.759 0.081
Hept Epox 0.047 0.019 2.509 0.013
Mirex -0.060 0.020 -3.086 0.002
p,p’-DDT -0.008 0.021 -0.383 0.702
Income:$10,000 to $14,999-0.031 0.086 -0.360 0.720
Income:$15,000 to $19,999 -0.003 0.083 -0.038 0.970
Income:$20,000 to $24,999 -0.001 0.082 -0.014 0.989
Income:$25,000 to $34,999 -0.014 0.085 -0.160 0.873
Income:$35,000 to $44,999 0.069 0.088 0.777 0.439
Income:$45,000 to $54,999 0.039 0.088 0.445 0.657
Income:$55,000 to $64,999 0.059 0.087 0.675 0.501
Income:$65,000 to $74,999 -0.048 0.083 -0.577 0.565
Income:$75,000 and Over 0.015 0.075 0.202 0.840
Ethnicity:Non-Hispanic Black 0.059 0.047 1.251 0.213
Ethnicity:Non-Hispanic White 0.016 0.036 0.435 0.664
Ethnicity:Other Hispanic 0.056 0.082 0.677 0.499
Ethnicity:Other Race
- Including Multi-Racial
-0.082 0.074 -1.109 0.269
Gender:Male -0.058 0.030 -1.952 0.053
Smoker:Yes -0.003 0.029 -0.087 0.930
D.3.3 Fractional factorial with covariate adjustment: Fisherian
analysis.
In this analysis mirex is the only pesticide that appears to have a significant
effect on BMI at the 0.05 level.
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Table 17: Saturated model
Estimate Std. Error t value Pr(>|t|)
(Intercept) 3.278 0.088 37.234 0.000
beta-Hex 0.033 0.023 1.459 0.1470
Hept Epox 0.042 0.022 1.892 0.061
Mirex -0.056 0.023 -2.428 0.017
p,p’-DDT -0.011 0.024 -0.461 0.645
beta-Hex:Hept Epox -0.006 0.023 -0.276 0.783
beta-Hex:Mirex -0.019 0.023 -0.844 0.400
Hept Epox:Mirex -0.014 0.023 -0.600 0.549
Income:$10,000 to $14,999 -0.035 0.088 -0.393 0.695
Income:$15,000 to $19,999 0.001 0.084 0.015 0.988
Income:$20,000 to $24,999 0.004 0.083 0.044 0.965
Income:$25,000 to $34,999 -0.008 0.086 -0.088 0.930
Income:$35,000 to $44,999 0.073 0.089 0.822 0.413
Income:$45,000 to $54,999 0.037 0.089 0.411 0.682
Income:$55,000 to $64,999 0.063 0.088 0.720 0.473
Income:$65,000 to $74,999 -0.049 0.084 -0.587 0.558
Income:$75,000 and Over 0.019 0.076 0.253 0.800
Ethnicity:Non-Hispanic Black 0.072 0.049 1.492 0.138
Ethnicity:Non-Hispanic White 0.022 0.037 0.598 0.551
Ethnicity:Other Hispanic 0.055 0.083 0.665 0.507
Ethnicity:Other Race
- Including Multi-Racial
-0.090 0.075 -1.198 0.233
Gender:Male -0.055 0.030 -1.830 0.069
Smoker:Yes -0.005 0.030 -0.155 0.877
77
3.0 3.1 3.2 3.3 3.4 3.5
−
0.
4
−
0.
2
0.
0
0.
2
0.
4
Predicted values
R
es
id
ua
ls
Residuals vs Fitted
1185
599
233
−2 −1 0 1 2
−
2
−
1
0
1
2
3
Theoretical Quantiles
St
d.
 d
ev
ia
nc
e 
re
si
d.
Normal Q−Q
599
1185
561
3.0 3.1 3.2 3.3 3.4 3.5
0.
0
0.
5
1.
0
1.
5
Predicted values
St
d.
 
de
vi
a
n
ce
 
re
si
d.
Scale−Location
599 1185
561
0.0 0.1 0.2 0.3 0.4
−
3
−
2
−
1
0
1
2
3
Leverage
St
d.
 P
e
a
rs
o
n
 r
e
si
d.
Cook's distance
Residuals vs Leverage
540
787
360
Figure 22: Basic diagnostics plot for the saturated model given in Table 17.
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Figure 23: Plots of simulated treatment effects estimated. Observed treat-
ment effect estimates plotted in red.
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